Diabetes is a condition that affects the way the body uses blood sugar, and it’s very common, affecting millions worldwide.
There are different medications to manage diabetes, and scientists are always exploring new options to improve the lives of people living with the condition.
Recently, some fresh discoveries from the University of Hong Kong have shed light on a new class of diabetes drugs known as Sodium-glucose cotransporter 2 inhibitors (SGLT2i), showing promise beyond just blood sugar control.
A Comparison of Diabetes Medications
Researchers at the University of Hong Kong have been studying and comparing the benefits of SGLT2 inhibitors with an older class of diabetes drugs called dipeptidyl peptidase-4 inhibitors (DPP4i).
The comparison aimed to understand which of the two offers more protection to the heart, kidneys, and respiratory system in people with type 2 diabetes.
Protecting the Kidneys and Lungs
The team used information from more than 30,000 patients with type 2 diabetes and discovered that SGLT2 inhibitors are highly effective in reducing the risk of severe kidney and lung diseases.
This is especially important because, in the past, research mainly focused on how these drugs can protect the heart and kidneys, leaving out their potential benefits for the lungs.
Patients using SGLT2 inhibitors showed a reduced risk of developing serious conditions like end-stage renal disease (a severe kidney disease) and obstructive airway disease (a severe lung disease), revealing that SGLT2 inhibitors could have more protective benefits compared to the older DPP4 inhibitors.
Weighing the Benefits and Risks
While the potential additional protections are promising, it’s crucial to remember that all medications have side effects.
In the case of SGLT2 inhibitors, users might experience an increased risk of infections in the genital and urinary tract and a higher risk of a serious condition called diabetic ketoacidosis.
So, it’s crucial for patients and doctors to discuss the benefits and risks before choosing this medication.
Conclusion
This recent study offers hope and a new perspective for people with type 2 diabetes, showing that SGLT2 inhibitors can do more than just manage blood sugar levels; they can also potentially protect the kidneys and lungs.
These findings underline the importance of exploring and considering all available treatment options for managing diabetes.
However, more research is still needed to fully understand how SGLT2 inhibitors provide these protections. It’s also important to stay informed about health and treatment options.
For instance, recent studies have shown that adequate sleep can help prevent vision loss in people with diabetes, and blueberries can offer substantial benefits to people with metabolic issues.
People considering new treatment options should always weigh the potential benefits against the possible risks and discuss these with their healthcare providers to make the most informed decisions regarding their health management strategies.
The study by Dr. Cheung Ching-lung and his team opens a new chapter in understanding and managing diabetes, offering a ray of hope to millions of people affected by this condition.
If you care about kidney health, please read studies about how to protect your kidneys from diabetes, and drinking coffee could help reduce the risk of kidney injury.
For more information about diabetes, please see recent studies about how to eat to prevent type 2 diabetes, and 5 vitamins that may prevent complications in diabetes.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
